Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-05

Clinical Trial Update: Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [Phase 2]

View source ↗

Summary

A Phase 2 study comparing immunoadsorption with intravenous immunoglobulin for chronic inflammatory demyelinating polyrneuropathy (CIDP) is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Immunoadsorption
  • Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University of Ulm | Conditions: CIDP | Phase 2 | Status: RECRUITING